These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 6507302)

  • 1. Combined noninvasive assessment of the patent ductus arteriosus in the preterm infant before and after indomethacin treatment.
    Smallhorn JF; Gow R; Olley PM; Freedom RM; Swyer PR; Perlman M; Rowe RD
    Am J Cardiol; 1984 Dec; 54(10):1300-4. PubMed ID: 6507302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous indomethacin therapy in preterm neonates with patent ductus arteriosus.
    Rajadurai VS; Yu VY
    J Paediatr Child Health; 1991 Dec; 27(6):370-5. PubMed ID: 1756081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response of the patent ductus arteriosus to indomethacin treatment.
    Ramsay JM; Murphy DJ; Vick GW; Courtney JT; Garcia-Prats JA; Huhta JC
    Am J Dis Child; 1987 Mar; 141(3):294-7. PubMed ID: 3812411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors associated with permanent closure of the ductus arteriosus: a role for prolonged indomethacin therapy.
    Quinn D; Cooper B; Clyman RI
    Pediatrics; 2002 Jul; 110(1 Pt 1):e10. PubMed ID: 12093991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indomethacin tocolysis increases postnatal patent ductus arteriosus severity.
    Hammerman C; Glaser J; Kaplan M; Schimmel MS; Ferber B; Eidelman AI
    Pediatrics; 1998 Nov; 102(5):E56. PubMed ID: 9794986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noninvasive assessment of indomethacin therapy in patent ductus arteriosus in preterm infants.
    Kashani IA; Nulton GD; Sahn DJ
    Clin Cardiol; 1986 Mar; 9(3):93-8. PubMed ID: 3948448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Late closure of the ductus arteriosus using indomethacin in the preterm infant.
    Kresch MJ; Moya FR; Ascuitto RJ; Ross-Ascuitto NT; Heusser F
    Clin Pediatr (Phila); 1988 Mar; 27(3):140-3. PubMed ID: 3342597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged versus short course of indomethacin for the treatment of patent ductus arteriosus in preterm infants.
    Herrera C; Holberton J; Davis P
    Cochrane Database Syst Rev; 2004; (1):CD003480. PubMed ID: 14974018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistent Doppler flow predicts lack of response to multiple courses of indomethacin in premature infants with recurrent patent ductus arteriosus.
    Keller RL; Clyman RI
    Pediatrics; 2003 Sep; 112(3 Pt 1):583-7. PubMed ID: 12949288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of oral ibuprofen and intravenous indomethacin for closure of patent ductus arteriosus in preterm infants.
    Chotigeat U; Jirapapa K; Layangkool T
    J Med Assoc Thai; 2003 Aug; 86 Suppl 3():S563-9. PubMed ID: 14700149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short versus prolonged indomethacin therapy for patent ductus arteriosus in preterm infants.
    Tammela O; Ojala R; Iivainen T; Lautamatti V; Pokela ML; Janas M; Koivisto M; Ikonen S
    J Pediatr; 1999 May; 134(5):552-7. PubMed ID: 10228288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atrial natriuretic peptide in the diagnosis of patent ductus arteriosus.
    Weir FJ; Smith A; Littleton P; Carter N; Hamilton PA
    Acta Paediatr; 1992 Sep; 81(9):672-5. PubMed ID: 1421905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral ibuprofen and indomethacin for treatment of patent ductus arteriosus in premature infants: a randomized trial at Ramathibodi Hospital.
    Supapannachart S; Limrungsikul A; Khowsathit P
    J Med Assoc Thai; 2002 Nov; 85 Suppl 4():S1252-8. PubMed ID: 12549803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Duration of indomethacin treatment of the preterm patent ductus arteriosus as directed by echocardiography.
    Carmo KB; Evans N; Paradisis M
    J Pediatr; 2009 Dec; 155(6):819-822.e1. PubMed ID: 19643435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of indomethacin in premature infants with patent ductus arteriosus: results of a national collaborative study.
    Gersony WM; Peckham GJ; Ellison RC; Miettinen OS; Nadas AS
    J Pediatr; 1983 Jun; 102(6):895-906. PubMed ID: 6343572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early closure of patent ductus arteriosus with indomethacin in preterm infants with idiopathic respiratory distress syndrome.
    Kääpä P; Lanning P; Koivisto M
    Acta Paediatr Scand; 1983 Mar; 72(2):179-84. PubMed ID: 6340412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness and side effects of an escalating, stepwise approach to indomethacin treatment for symptomatic patent ductus arteriosus in premature infants below 33 weeks of gestation.
    Sperandio M; Beedgen B; Feneberg R; Huppertz C; Brüssau J; Pöschl J; Linderkamp O
    Pediatrics; 2005 Dec; 116(6):1361-6. PubMed ID: 16322159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral ibuprofen in early curative closure of patent ductus arteriosus in very premature infants.
    Cherif A; Jabnoun S; Khrouf N
    Am J Perinatol; 2007 Jun; 24(6):339-45. PubMed ID: 17564958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiographic and echocardiographic evaluation of newborns treated with indomethacin for patent ductus arteriosus.
    Edwards DK; Higgins CB; Merritt TA; DiSessa TG; Friedman WF
    AJR Am J Roentgenol; 1978 Dec; 131(6):1009-13. PubMed ID: 104563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parenteral indomethacin for closure of the patent ductus arteriosus. Clinical experience with 67 preterm infants.
    Harris JP; Merritt TA; Alexson CG; Longfield L; Manning JA
    Am J Dis Child; 1982 Nov; 136(11):1005-8. PubMed ID: 7124692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.